Is Vertex Stock Still a Good Buy?
Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…
Sell
47
DRD Quote, Financials, Valuation and Earnings
Last price:
$14.05
Seasonality move
:
-5.04%
Day range:
$14.45 - $14.92
52-week range:
$7.64 - $17.60
Dividend yield:
1.85%
P/E ratio:
13.74x
P/S ratio:
3.33x
P/B ratio:
3.15x
Volume:
294K
Avg. volume:
610.4K
1-year change:
91.03%
Market cap:
$1.3B
Revenue:
$333M
EPS (TTM):
$1.08
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, DRDGold has 9.06% upside to fair value with a price target of $16.25 per share.
DRD vs. S&P 500
-
Over the past 5 trading days, DRDGold has underperformed the S&P 500 by -4.38% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
DRDGold does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
DRDGold has grown year-over-year revenues for 2 quarters straight. In the most recent quarter DRDGold reported revenues of --.
Earnings Growth
-
DRDGold has grown year-over-year earnings for 1 quarter straight. In the most recent quarter DRDGold reported earnings per share of --.
Enterprise value:
1.2B
EV / Invested capital:
--
Price / LTM sales:
3.33x
EV / EBIT:
9.40x
EV / Revenue:
3.22x
PEG ratio (5yr expected):
0.10x
EV / Free cash flow:
32.17x
Price / Operating cash flow:
16.36x
Enterprise value / EBITDA:
8.15x
Gross Profit (TTM):
$129.5M
Return On Assets:
17.87%
Net Income Margin (TTM):
24.21%
Return On Equity:
27.94%
Return On Invested Capital:
24.25%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2013-06-30 | 2014-06-30 | 2015-06-30 | 2014-06-30 | 2015-06-30 | |
| Income Statement | ||||||
| Revenue | $236.1M | $174.5M | $183.9M | $42.4M | $46.3M | |
| Gross Profit | $51M | $11.9M | $13.9M | $3.4M | $2.9M | |
| Operating Income | $42.9M | $4.7M | $8.1M | $7M | $3.9M | |
| EBITDA | $40.3M | $16.9M | $29.2M | $8.1M | $12.4M | |
| Diluted EPS | $0.20 | -$0.12 | $0.13 | -$0.01 | $0.12 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | -- | $87.9M | |
| Total Assets | -- | -- | -- | -- | $548.8M | |
| Current Liabilities | -- | -- | -- | -- | $37.5M | |
| Total Liabilities | -- | -- | -- | -- | $140.3M | |
| Total Equity | -- | -- | -- | -- | $408.5M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2013-06-30 | 2014-06-30 | 2015-06-30 | 2014-06-30 | 2015-06-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $57M | $7.8M | $24.8M | $2.1M | $6.9M | |
| Cash From Investing | -$48.7M | -$16.6M | -$3.3M | -$2.3M | $1.1M | |
| Cash From Financing | $646.1K | -$7.4M | -$11.4M | -$304.7K | -$4.5M | |
| Free Cash Flow | $57M | $7.8M | $16.9M | $2.1M | -$1M | |
DRD
Sector
Market Cap
$1.3B
$18.2M
Price % of 52-Week High
84.66%
62.04%
Dividend Yield
1.85%
0%
Shareholder Yield
--
1.27%
1-Year Price Total Return
91.03%
-15.37%
Beta (5-Year)
0.387
0.785
Dividend yield:
1.85%
Annualized payout:
$0.45
Payout ratio:
--
Growth streak:
1 years
Technicals
8-day SMA
Sell
Level
$15.37
200-day SMA
Buy
Level
$10.81
Bollinger Bands (100)
Buy
Level
9.22 - 14.36
Chaikin Money Flow
Buy
Level
193.3K
20-day SMA
Sell
Level
$15.34
Relative Strength Index (RSI14)
Sell
Level
49.40
ADX Line
Sell
Level
19.72
Williams %R
Buy
Level
-85.443
50-day SMA
Buy
Level
$13.95
MACD (12, 26)
Buy
Level
1.53
25-day Aroon Oscillator
Buy
Level
28
On Balance Volume
Neutral
Level
585K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.7729)
Buy
CA Score
(Annual)
Level (1.9242)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (10)
Buy
Ohlson Score
Level (-2.316)
Buy
Piotroski F Score
(Annual)
Level (6)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
DRDGold Ltd is a South African gold mining company engaged in surface gold tailings retreatment including exploration, extraction, processing, and smelting. Its reportable operating segments are; Ergo, FWGR, and Corporate office and other reconciling items. The Ergo is a surface gold retreatment operation that treats old slime dams and sand dumps to the south of Johannesburg's central business district as well as the East and Central Rand goldfields; and the FWGR which is a surface gold retreatment operation and treats old slime dams in the West Rand goldfields. The Ergo segment derives a vast majority of the company's revenue.
Stock Forecast FAQ
In the current month, DRD has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The DRD average analyst price target in the past 3 months is $16.25.
-
Where Will DRDGold Stock Be In 1 Year?
According to analysts, the consensus estimate is that DRDGold share price will rise to $16.25 per share over the next 12 months.
-
What Do Analysts Say About DRDGold?
Analysts are divided on their view about DRDGold share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that DRDGold is a Sell and believe this share price will drop from its current level to $16.25.
-
What Is DRDGold's Price Target?
The price target for DRDGold over the next 1-year time period is forecast to be $16.25 according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is DRD A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for DRDGold is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of DRD?
You can purchase shares of DRDGold via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase DRDGold shares.
-
What Is The DRDGold Share Price Today?
DRDGold was last trading at $14.05 per share. This represents the most recent stock quote for DRDGold. Yesterday, DRDGold closed at $14.90 per share.
-
How To Buy DRDGold Stock Online?
In order to purchase DRDGold stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Okta Stock Finally Gaining Investor Confidence?
Given how digital transformation has proliferated, cyberattacks have also been…
Is The Trade Desk the Best Advertising Stock Now?
The worldly backdrop is now shrouded in heavy uncertainty and…
Stock Ideas
Buy
61
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Sell
50
RGC alert for May 1
Regencell Bioscience Holdings [RGC] is up 8.33% over the past day.
Sell
38
WGS alert for May 1
GeneDx Holdings [WGS] is down 1.57% over the past day.
Sell
43
VICR alert for May 1
Vicor [VICR] is up 1.88% over the past day.
